Nonsurgical management of urolithiasis: An overview of expulsive therapy

Journal of Endourology

Volumn 19, Issue 7, 2005, Pages 759-767

  Healy, K A ^a   Ogan, Kenneth ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; DEFLAZACORT; DIAZEPAM; DICLOFENAC; HYDROXYPROGESTERONE; INDOMETACIN; METHYLPREDNISOLONE; NIFEDIPINE; ORCIPRENALINE; PHENTOLAMINE; PHLOROGLUCINOL; PLACEBO; PREDNISOLONE; PROSTAGLANDIN SYNTHASE INHIBITOR; SPASMOLYTIC AGENT; TAMSULOSIN; THEOPHYLLINE;

ABSENTEEISM; ANALGESIA; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; EXTRACORPOREAL LITHOTRIPSY; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPOTENSION; KIDNEY FUNCTION; NEPHROLITHOTOMY; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; REVIEW; STOMACH PAIN; URETER STONE; URETEROSCOPY; UROLITHIASIS;

ADRENAL CORTEX HORMONES; ADRENERGIC ALPHA-AGONISTS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; HUMANS; HYDROXYPROGESTERONES; URINARY CALCULI;

EID: 26444569390     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2005.19.759     Document Type: Review

References (25)

1. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, Macaluso JN Jr. Ureteral Stones Clinical Guidelines Panel Summary Report on the Management of Ureteral Calculi. The American Urological Association. J Urol 1997;158:1915-1921.
2. Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993;24:172-176.
3. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: A guide for patient education. J Urol 1999;162:688-690; discussion 690-691.
4. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003;170:2202-2205.
5. Ibrahim AI, Shetty SD, Awad RM, Patel KP. Prognostic factors in the conservative treatment of ureteric stones. Br J Urol 1991;67: 358-361.
6. van Wagenen G, et al. An experimental examination of factors causing ureteral dilatation of pregnancy. J Urol 1939;42:1010.
7. Traut HF, et al. Physiological changes in the ureter associated with pregnancy. Surg Gynecol Obstet 1936;62:65.
8. Hundley JM Jr, Diehl WK, Diggs ES. Hormonal influences upon the ureter. Am J Obstet Gynecol 1942;44:858.
9. Raz S, Zeigler M, Caine M. Hormonal influence on the adrenergic receptors of the ureter. Br J Urol 1972;44:405.
10. Kumar D. In vitro inhibitory effect of progesterone on extraurterine human smooth muscle. Am J Obstet Gynecol 1962;84:1300.
11. Guyer PB, Delany D. Urinary tract dilatation and oral contraceptives. Br Med J 1970;4:588.
12. Marshall S, Lyon RP, Minkler D. Ureteral dilatation following use of oral contraceptives. JAMA 1966;198:782.
13. Lonsdale DK, Sutor DJ, Wooley SE. Composition of urinary calculi by X-ray diffraction: Collected data from various localities. Br J Urol 1968;40:402.
14. Perlow DL. The use of progesterone for ureteral stones: A preliminary report. J Urol 1980;124:715-716.
15. Mikkelsen AL, Meyhoff HH, Lindahl F, Christensen J. The effect of hydroxyprogesterone on ureteral stones. Int Urol Nephrol 1988;20:257-260.
16. Al-Waili NS. Prostaglandin synthetase inhibition with indomethacin rectal suppositories in the treatment of acute and chronic urinary calculus obstruction. Clin Exp Pharmacol Physiol 1986;13:195-199.
17. Ahmad M, Chaughtai MN, Khan FA. Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. JPMA J Pakistan Med Assoc 1991;41:268-270.
18. Laerum E, Ommundsen OE, Gronseth JE, Christiansen A, Fagertun HE. Oral diclofenac in the prophylactic treatment of recurrent renal colic: A double-blind comparison with placebo. Eur Urol 1995;28:108-111.
19. Borghi L, Meschi T, Amato F, Novarini A, Giannini A, Quarantelli C, Mineo F. Nifedipine and methylprednisolone in facilitating ureteral stone passage: A randomized, double-blind, placebo-controlled study [see comment]. J Urol 1994;152:1095-1098.
20. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000;56:579-582.
21. Clayman RV. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. J Urol 2002;167:797-798.
22. Saita A, Bonaccorsi A, Marchese F, Condorelli SV, Motta M. Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int 2004;72(suppl 1):43-45.
23. Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker tamsulosin. Int Urol Nephrol 2002;34: 25-29.
24. Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004;172:568-571.
25. Lotan Y, Gettman MT, Roehrborn CG, Cadeddu JA, Pearle MS. Management of ureteral calculi: A cost comparison and decision making analysis. J Urol 2002;167:1621-1629.